Research Article
Propranolol Treatment for Infantile Hemangiomas: Short-Term Adverse Effects and Follow-Up to Age Two
Table 6
Height and body weight of 2-year-old children.
| Characteristic | (%) | Height, cm | | BW, kg | | Average | | <−2SD | >+2SD | Average | | <−2SD | >+2SD | /M (Q25,Q75) | |
| Gender | Female | 199 (68.2) | 87.9 ± 3.2 | 0.043# | 3 | 3 | 12.00 (11.00, 12.60) | 0.937 | 1 | 3 | Male | 93 (31.8) | 98.3 ± 3.3 | 0.017# | 1 | 2 | 12.50 (11.80, 13.20) | 0.737 | 0 | 2 |
| Starting age | ≤3 months | Female | 82 (28.1) | 87.0 ± 2.8① | 0.751 | 0 | 1 | 12.00 (11.00, 12.65)② | 0.776 | 0 | 2 | Male | 35 (12.0) | 89.0 (87.0, 90.0)③ | 0.514 | 1 | 1 | 12.50 (12.00, 12.80)④ | 0.183 | 0 | 1 | >3 months | Female | 117 (40.1) | 87.9 ± 3.5① | 0.025# | 3 | 2 | 11.85 ± 1.12② | 0.891 | 1 | 1 | Male | 58 (19.9) | 89.8 ± 3.7③ | 0.010# | 0 | 1 | 12.60 (11.80, 13.50)④ | 0.222 | 0 | 1 |
| Preterm birth | Female | 15 (5.1) | 88.1 ± 3.6⑤ | 0.459 | 0 | 1 | 11.92 ± 1.44⑥ | 0.820 | 0 | 2 | Male | 10 (3.4) | 87.9 ± 3.0⑦ | 0.527 | 0 | 0 | 12.17 ± 0.86⑧ | 0.201 | 0 | 0 | Term birth | Female | 184 (63.0) | 87.7 ± 3.2⑤ | 0.055 | 3 | 2 | 12.00 (11.00, 12.60)⑥ | 0.821 | 1 | 1 | Male | 83 (28.4) | 89.5 ± 3.3⑦ | 0.008# | 1 | 2 | 12.50 (12.00, 13.20)⑧ | 0.513 | 0 | 2 |
| Adverse effect | No | Female | 162 (55.5) | 87.9 ± 3.2⑨ | 0.013# | 2 | 2 | 11.94 ± 1.12⑩ | 0.593 | 0 | 1 | Male | 76 (26.0) | 89.3 ± 3.2⑪ | 0.032# | 1 | 0 | 12.50 (11.80, 13.20)⑫ | 0.768 | 0 | 1 | Yes | Female | 37 (12.7) | 86.9 ± 3.2⑨ | 0.368 | 1 | 1 | 12.00 (10.75, 12.00)⑩ | 0.462 | 1 | 2 | Male | 17 (5.8) | 89.6 ± 3.7⑪ | 0.319 | 0 | 2 | 12.87 ± 1.61 ⑫ | 0.794 | 0 | 1 |
|
|
Wilcoxon signed-rank test: compared with standard reference, #, Mann-Whitney U-test: ① , ② , ③ , ④ , ⑥ , ⑧ , ⑩ , ⑫ , t-test: ⑤ , ⑦ , ⑨ , ⑪ . |